NEW YORK (GenomeWeb) – Talis Biomedical announced today it has been awarded a five-year grant for up to $5.6 million grant from the National Institute of Allergy and Infectious Diseases. The funding will support development of a point-of-care system enabling enrichment, identification, and phenotypic antibiotic susceptibility testing of pathogens directly from whole blood.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.